Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues
Ascendis Pharma A/S (ASND) had Profit Margin of 255.21% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$288.62M |
|
$736.58M |
|
$20.50M |
|
$268.12M |
|
$259.58M |
|
$29.04M |
|
$-85.43M |
|
$-56.39M |
|
$-56.39M |
|
$736.58M |
|
$736.58M |
|
$736.58M |
|
$736.58M |
|
$29.04M |
|
$33.98M |
|
61.68M |
|
64.52M |
|
$11.94 |
|
$11.41 |
|
| Balance Sheet Financials | |
$1.31B |
|
$159.08M |
|
$1.03B |
|
$2.34B |
|
$1.32B |
|
$451.90M |
|
$454.75M |
|
$1.77B |
|
$571.12M |
|
$566.81M |
|
$571.12M |
|
62.11M |
|
| Cash Flow Statement Financials | |
$-9.04M |
|
$-7.90M |
|
$-43.11M |
|
$721.01M |
|
$670.43M |
|
$-50.59M |
|
$35.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.00 |
|
-- |
|
-- |
|
0.44 |
|
1.84 |
|
92.90% |
|
10.06% |
|
10.06% |
|
-- |
|
-19.54% |
|
|
Profit Margin |
255.21% |
$-18.06M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.06 |
|
1.25 |
|
71.75 |
|
128.97% |
|
129.95% |
|
31.42% |
|
72.00% |
|
$9.20 |
|
$-0.28 |
|
$-0.14 |
|